申请人:Reddy Raja K.
                            
                            
                                公开号:US20050182252A1
                            
                            
                                公开(公告)日:2005-08-18
                            
                            Compounds of Formula I, stereoisomers, and pharmaceutically acceptable salts or prodrugs thereof, their preparation, and their uses for the treatment of hepatitis C viral infection are described:
                            化合物I的配方、立体异构体以及其药用可接受的盐或前药,它们的制备以及它们用于治疗丙型肝炎病毒感染的用途被描述: